- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 8, 2024 | 34.33M sh |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $15.12M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $19.68M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $250.98M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $248.03M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $352.06M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $351.12M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $9.78M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $8.5M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 35.37M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$612K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.13 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.13 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $3.53M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$1.63M |
| Revenue | Q1 2024 · Mar 31, 2023 | $11.13M |